#clinical-trials
clinicaltrials-mcp added to PyPI
Conversational access to ClinicalTrials.gov — an MCP server for pharma analysts, CRO teams, and health-tech builders
Clinical Trials Market Insights and Growth Outlook to 2033 - Shift Towards Patient-Centric and Technology-Driven Trial Models Transforming the Industry
Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, and strategic partnerships further drive expansion in this evolving sector. Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, a…
Drug Trials Snapshots: QFITLIA
QFITLIA is an antithrombin-directed small interfering ribonucleic acid indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without fac…
Clinical Trials Market Analysis/Forecasts 2026-2034 by Phases, Indications, Study Designs, Countries and Competitive Landscape
The clinical trials market is forecasted to experience strong growth, expanding from $92.63 billion to $158.1 billion between 2025 and 2034, driven by rising pharmaceutical and biotechnology R&D, chronic disease prevalence, and demand for innovative treatment…